| Description | MTT,ayellowtetrazole,isreducedtopurpleformazaninlivingcells,andusedforassessingcellmetabolicactivity. |
|---|---|
| InVitro | MTTisusedinconjunctionwithrhodamineBtomeasuremitochondrialmembranepotential.MTT-formazanisgeneratedinmitochondriaactsasafluorescencequencherforrhodaminethatdistributesacrossmembranesofviablecellsaccordingtomembranepotential.IntheabsenceofmPMS,cellularreductionofMTTisstrong.MTTismembrane-impermeablewhenincorporatedintolargeunilamellarliposomes,andthereforeitistakenupbycellsviaendocytosis[1]. |
| ClinicalTrial | ViewMoreCollapse |
| References |
|
| PreparingStockSolutions |
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent. | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| References |
|
| MolecularWeight | 414.32 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Formula | C₁₈H₁₆BrN₅S | ||||||||||||
| CASNo. | 298-93-1 | ||||||||||||
| Storage |
| ||||||||||||
| Shipping | RoomtemperatureincontinentalUS;mayvaryelsewhere | ||||||||||||
| Solvent&Solubility | DMSO:≥32mg/mL;H2O:0.88mg/mL(Needultrasonicandwarming) *"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation=""> Purity:99.59% |
